James Investment Research’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,192	Closed	-$102K	–	315
2023 Q3	$102K	Hold	3,192	–	–	0.01%	270
2023 Q2	$107K	Buy	3,192 +2,008	+170%	+$67.5K	0.01%	267
2023 Q1	$49K	Buy	+1,184	New	+$49K	0.01%	366